Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to FAM178A (AL138762.1)
- Target
- AL138762.1
- Molecular classification
- Long non-coding RNA, antisense RNA
01
Overview
This entry describes a human long non-coding RNA annotated as "novel transcript, antisense to FAM178A." It is encoded on the opposite strand of the FAM178A locus and is classified as an antisense transcript. Antisense transcripts are a subset of long non-coding RNAs that frequently regulate their associated protein-coding genes through various mechanisms, including altering chromatin structure, stabilizing or destabilizing sense mRNA, or modulating transcriptional activity[5]. No evidence exists that this RNA encodes a protein or that it functions as a receptor, enzyme, transporter, or similar therapeutic target class[1][3][5]. There are no established aliases beyond AL138762.1 and no known disease associations, biomarkers, or drug interactions. Its molecular classification is best described as an antisense long non-coding RNA[1][3][5].
- Other names
- AL138762.1
02
Biological functions
Antisense regulation of gene expression (general class for lncRNAs)specific biological function not established for this transcriptpossible involvement in chromatin modulation or influencing FAM178A expression by antisense pairing
03
Disease associations
Other (No specific disease role reported; general lncRNA/antisense roles may include regulatory functions in development or disease, but no direct link established)
Beyond the preview
Go deeper on Novel transcript, antisense to FAM178A (AL138762.1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to FAM178A (AL138762.1).